UT-MD Anderson Cancer Center: Lung Cancer Study Finds New Target For Treatment Resistance After EGFR Inhibitors
February 14, 2023
February 14, 2023
HOUSTON, Texas, Feb. 14 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Feb. 13, 2023:
* * *
Preclinical study demonstrates targeting CD70 with cell therapies, antibody-drug conjugates can eliminate resistant tumor cells
* * *
Researchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed on drug-resistant cancer cells in EGFR-mutant non-small . . .
* * *
Preclinical study demonstrates targeting CD70 with cell therapies, antibody-drug conjugates can eliminate resistant tumor cells
* * *
Researchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed on drug-resistant cancer cells in EGFR-mutant non-small . . .